Ultralife Corporation (ULBI) Aandelenanalyse

Bedrijfsoverzicht

Ultralife Corporation is a global designer, manufacturer, and maintainer of power, communication, and electronics systems that serves diverse industrial applications through its specialized subsidiaries. Operating within the Industrials sector and specifically the Electrical Equipment & Parts industry, the company focuses on the production of critical energy solutions and communications infrastructure for worldwide markets. The enterprise currently commands a market capitalization of $113.18M and generates annual revenue of $191.16M, while employing a workforce of 678 individuals across its operational segments. These financial dimensions indicate that Ultralife functions as a mid-cap entity with a substantial revenue base relative to its valuation, suggesting a business model where earnings generation is currently constrained despite solid top-line activity and a significant operational footprint.

Financiële gezondheid

The company reported revenue of $191.16M over the trailing twelve months, yet this top-line performance masks a net income loss of $-5,898,000, revealing a cost structure where operating expenses significantly outpace profitability. Despite the negative net income, the firm maintains an EBITDA of $9.48M, indicating that cash earnings before interest, taxes, depreciation, and amortization remain positive even after accounting for the substantial losses reflected in the bottom line. Ultralife generated free cash flow of $3.52M, which provides a crucial buffer for financial flexibility, allowing the business to meet obligations and fund operations without relying solely on external financing. The gross margin stands at 24.1%, suggesting healthy pricing power on core products, while the operating margin of -3.8% and profit margin of -3.1% highlight significant overhead pressures or one-time costs impacting the bottom line. On the balance sheet, the company holds $9.35M in cash against $52.98M in debt, resulting in a debt-to-equity ratio of 40.72, which characterizes a highly leveraged financial position rather than a conservative one. Short-term liquidity is supported by a current ratio of 2.83, indicating that the firm possesses more than twice the current assets necessary to cover its current liabilities. Return on Equity is recorded at -4.5% and return on assets at 1.1%, metrics that collectively suggest management effectiveness is currently challenged by the erosion of shareholder value and inefficient asset utilization relative to the equity base.

Waarderingsbeoordeling

The trailing twelve-month P/E ratio is listed as N/A due to negative earnings, whereas the forward P/E is 7.55, implying that the market anticipates a significant turnaround in profitability that will drastically reduce the valuation multiple in future periods. The price-to-book ratio of 0.87 indicates that the market is valuing the company at a discount to its book value, suggesting a lack of market premium or a perception of high risk associated with the asset base. Alternative valuation metrics such as a price-to-sales ratio of 0.59 and an EV/EBITDA of 16.56 offer context for the company's valuation relative to sales volume and operational cash generation before capital structure adjustments. The stock has traded between a 52-week low of $4.07 and a 52-week high of $9.52, and without the current share price explicitly defined in the provided facts, the position relative to this range cannot be calculated; however, the wide spread suggests potential volatility or a lack of consensus on the fair value. The beta of 0.72 indicates that the stock price exhibits lower volatility than the broader market, moving approximately 28% less than the market average during periods of fluctuation.

Growth & Income

Revenue growth year-over-year has accelerated to 10.6%, signaling an expanding market share or successful product adoption, while earnings growth is N/A due to the absence of positive reported earnings to calculate a meaningful year-over-year change. Since the earnings growth rate is not applicable rather than being faster or slower than revenue growth, the company is currently in a phase where top-line expansion has not yet translated into bottom-line profitability. Ultralife does not pay a dividend, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, meaning the company reinvests all available earnings back into the business rather than distributing cash to shareholders. The overall growth and income profile is defined by strong revenue expansion coupled with a complete absence of current income distribution, reflecting a capital allocation strategy focused on operational recovery and future growth rather than immediate shareholder returns.